Skip to main content
Premium Trial:

Request an Annual Quote

NFTs of Nobel-Linked Work

The University of California, Berkeley, is auctioning non-fungible tokens linked to digitized versions of patent disclosures for two Nobel Prize-winning research projects.

According to the university, it will be auctioning NFTs associated with Jennifer Doudna's CRISPR-Cas9 work and with James Allison's immunotherapy work, for which they won Nobel Prizes in 2020 and 2018, respectively. NFTs rely on blockchains to provide a certificate of authenticity for digital objects, in this case the patent disclosure paperwork. The university is to retain ownership of the patents.

"Someone might ask, 'Why would I want a digital version of some internal university form?' Because it represents something magnificent," Rich Lyons, UC Berkeley's chief innovation & entrepreneurship officer, says in a statement. The funds raised through the auction are to go toward research and innovation at Berkeley.

These aren't the first genome-related NFTs. In April, Nebula Genomics announced it was putting up George Church's genome — Harvard's Church is a co-founder of the company — for sale as an NFT.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.